
JNJ
Johnson & Johnson
25
On watch
JNJ in Healthcare, Biotech & Devices
The thesis
JNJ is tied to themes that are active in the market right now. Its Decifer score reflects how well those forces line up with its business, plus the financial data we have. The numbers and analyst views below give the detail.
Why now
The market forces active right now are aligned with the company's core business exposure. The timing reflects the intersection of theme strength and available catalyst data.
What to watch
Watch for changes in the Decifer score and in what analysts say. The next earnings report and any change to the company's outlook matter most in the near term.
Key risks
Data availability limits full scoring across all dimensions. Market forces can reverse rapidly; theme exposure does not guarantee the price follows. Fundamental valuation data may not reflect the most recent quarterly results.
Theme exposure
Healthcare, Biotech & Devices
DirectJohnson & Johnson sits in the large-cap pharma layer of the Healthcare, Biotech & Devices story.
Market intelligence only. Not financial advice. Not a recommendation.